Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
Kelechi Njoku, Chloe E. Barr, Emma J. Crosbie
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

An Overview of Endometrial Cancer with Novel Therapeutic Strategies
Theresa Kuhn, Saeeda Dhanani, Sarfraz Ahmad
Current Oncology (2023) Vol. 30, Iss. 9, pp. 7904-7919
Open Access | Times Cited: 25
Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer—Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects
Roberto Piergentili, Giuseppe Gullo, Giuseppe Basile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11356-11356
Open Access | Times Cited: 23
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando O. Recio, Carly Bess Scalise, Paul Loar, et al.
Gynecologic Oncology (2024) Vol. 182, pp. 63-69
Open Access | Times Cited: 9
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
Kelechi Njoku, Chloe E. Barr, Neal C. Ramchander, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272232-e0272232
Open Access | Times Cited: 32
Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis
Pengtian Ji, Junjun He
Biomarkers in Medicine (2024) Vol. 18, Iss. 7, pp. 345-356
Closed Access | Times Cited: 6
Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy
Ioana-Stefania Bostan, Mirela Mihăilă, Viviana Roman, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2027-2027
Open Access | Times Cited: 6
Prediction of Deep Myometrial Infiltration, Clinical Risk Category, Histological Type, and Lymphovascular Space Invasion in Women with Endometrial Cancer Based on Clinical and T2-Weighted MRI Radiomic Features
Xingfeng Li, Michele Dessi, Diana Marcus, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2209-2209
Open Access | Times Cited: 14
Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer – Implications for the Fertility-sparing Process: Clinical, Biological and Legal Aspects
Roberto Piergentili, Giuseppe Gullo, Giuseppe Basile, et al.
(2023)
Open Access | Times Cited: 14
Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result–based analysis
Qing Xue, Wenqiang Che, Lujiadai Xue, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10917-10930
Open Access | Times Cited: 12
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
Kelechi Njoku, Andrew Pierce, Bethany Geary, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 9, pp. 1723-1732
Open Access | Times Cited: 11
Applying Techniques From Precision Medicine to Predict Challenging Behavior and Inform Clinical Resource Allocation
Samuel L. Morris, P. Raymond Joslyn
Behavior Modification (2025)
Closed Access
Clinical translation of metabolomics markers in endometrial carcinoma
Nur Fatin Nabilah Mohd Sahardi, M Vishnu Priya, Suzana Makpol, et al.
Journal of Obstetrics and Gynaecology Research (2025) Vol. 51, Iss. 3
Closed Access
An update on nanoformulations with FDA approved drugs for female reproductive cancer
M. Thanga Raj, Abha Meena, Richa Seth, et al.
Journal of Microencapsulation (2025), pp. 1-34
Closed Access
Real-World Molecular Testing Rates and Patterns in Patients With Primary Advanced or Recurrent Endometrial Cancer in the United States
Yilin Chen, Solomon J. Lubinga, Troy Williams, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe
Sneha S. Kelkar, Vimalanand S. Prabhu, Jingchuan Zhang, et al.
Archives of Gynecology and Obstetrics (2024) Vol. 309, Iss. 6, pp. 2833-2841
Open Access | Times Cited: 3
Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis
Xieyan Yu, Xiaoxing Zhang
Biomarkers in Medicine (2024) Vol. 18, Iss. 6, pp. 279-289
Closed Access | Times Cited: 3
Frailty and the Survival of Patients With Endometrial Cancer: A Meta‐Analysis
Shanshan Jia, Min Zhang
Research in Nursing & Health (2025)
Closed Access
Expression and prognostic value of EGF-like domain multiple 6 in uterine corpus endometrial carcinoma and its correlation with immune cell infiltration
Qiannan Li, Nuerbiya Muheteer, Gulibositan Ayoufu, et al.
Research Square (Research Square) (2025)
Closed Access
Molecular landscape of endometrioid Cancer: Integrating multiomics and deep learning for personalized survival prediction
Behnaz Haji Molla Hoseyni, Hossein Lanjanian, Yasaman Zohrab Beigi, et al.
Computers in Biology and Medicine (2025) Vol. 192, pp. 110284-110284
Closed Access
Unraveling the relationship between the renin–angiotensin system and endometrial cancer: a comprehensive review
Nihad Ashraf Khan, Deena Elsori, Gowhar Rashid, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Diagnostic, prognostic, and predictive importance of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and CA125 in endometrial hyperplasia and carcinoma
Bharti Kumari, Debaditya Haldar, Guddi R. Singh, et al.
Indian Journal of Pathology and Microbiology (2024) Vol. 67, Iss. 3, pp. 581-584
Open Access | Times Cited: 3
Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
Kelechi Njoku, Chloe E. Barr, Caroline J. J. Sutton, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3306-3306
Open Access | Times Cited: 14
Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
Kelechi Njoku, Heather Agnew, Emma J. Crosbie
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Determination of monosaccharide composition in human serum by an improved HPLC method and its application as candidate biomarkers for endometrial cancer
Yulong Chen, Yao Qin, Xuan Zeng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
Damian J. Ralser, Mateja Condic, Niklas Klümper, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2417-2424
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top